Werner Wenning

Werner Wenning

Werner Wenning

Werner Wenning has been Chairman of the Board of Management of Bayer AG since April 26, 2002.

Born on October 21, 1946 in Leverkusen-Opladen, Wenning joined Bayer AG in Leverkusen as a commercial trainee on April 1, 1966. He then took a year’s training in finance and accounting and worked for a further year in the Corporate Auditing Department. From 1970 to 1975 he established and managed the finance and accounting department of Bayer Industrial S.A., a company that had just been formed in Lima, Peru.

On his return to Germany he worked for another three years in Corporate Auditing, returning to Lima in 1978 to become Managing Director and administrative head of the Peruvian company.

In 1983, Wenning was appointed head of the staff department of what was then the Health Care Sector in Leverkusen. Three years later he switched to the Plastics Business Group as head of marketing for thermoplastics, and in 1987 assumed responsibility for that business group’s worldwide marketing operations.

On April 1, 1991 he was seconded for a year to the Treuhandanstalt privatization agency in Berlin. In 1992 Wenning went abroad again, this time to Barcelona as Managing Director of Bayer Hispania Industrial S.A. and Senior Bayer Representative for Spain. In April 1996 he became head of Corporate Planning and Controlling in Leverkusen. He was appointed to the Board of Management of Bayer AG in February 1997.

Wenning holds a number of offices outside Bayer. He is, for example:
– President of the German Chemical Industry Association (VCI), Frankfurt;
– a member of the supervisory boards of Gerling-Konzern Versicherungs-Beteiligungs-AG and Henkel KGaA.

Werner Wenning is married with two grown-up daughters.
Bild Download Bayer HealthCare: a health care company of world renown

Bayer HealthCare
The activities of Bayer HealthCare range from world-famous
medicines such as Aspirin through innovative diagnostic technologies and modern animal health products to research.
This independent subgroup thus makes an important contribution
to improving the health of people and animals. More about Bayer

BayNews – Company news

2005-10-21 Bayer wins approval for Avelox® (Moxifloxacin) in Japan, the world’s second largest pharmaceutical
market.

2005-10-20 International launch of new animal health product in New Zealand: Experts Conquer Parasites Just as Sir Edmund Hillary once Conquered Mount Everest.

2005-10-18 TB Alliance and Bayer Launch Historic Global Drug Trails for Tuberculosis: Phase II Trials to Study Potential of Moxifloxacin to Shorten TB Treatment.

Webzine The Bayer Magazine on the Web The pilgrim father
One million people from 190 countries welcomed the new pontiff, Benedict XVI, to Cologne in August. Among them was Bill Fratangelo, an employee at Bayer Corporate & Business Services in Pittsburgh, who traveled with his daughter Megan and a group of young people from his parish.

Access to and use of this website are subject to the following conditions. Please do not use this website unless you agree with these conditions. This website has been developed by the Bayer CropScience Marketing Services/Research Triangle Park, North Carolina (hereinafter to be referred to as BAYER) and is administrated by the same. We reserve the right to discontinue or to make partial or complete modifications to this website or to the General Conditions of Use, to our General Terms and Conditions, and to our Conditions of Sale and Delivery. Please note that we may make such changes at our own discretion and without prior announcement. We must therefore ask you, next time you visit this website, to view the conditions again and to note any changes or amendments that may have been made.
Surrender of use and benefit

All details, documents and illustrations published on this website are the sole property of BAYER. Any permission to use the same is granted on the proviso that the relevant copyright note is displayed on all copies, that such details are only used for personal purposes, that they are not exploited commercially, that the details are not modified in any way and that all illustrations gained from the website are only used in conjunction with the accompanying text.
Trademarks and Copyright

All trademarks on this website are the property of the Bayer Group, unless otherwise noted or in any other way perceivable as third party rights. Any unauthorized use of these trademarks or other materials is expressly prohibited and constitutes a violation of copyright, trademark law or other industrial property rights.
Limited liability

Bayer AG has compiled the detailed information provided on this website from internal and external sources to the best of its knowledge and belief, using professional diligence. We endeavor to expand and update this range of information on an ongoing basis. The information on this website is purely for the purpose of presenting BAYER and its products and services. However, no representation is made or warranty given, either expressly or tacitly, for the completeness or correctness of the information on this website. In particular, we must ask you to be aware that this information may no longer be up to date. We therefore recommend that you check any information you obtain from this website prior to using it in whatever form. Advice given on this website does not exempt you from conducting your own checks on our latest advice – particularly our safety datasheets and technical specifications – and on our products, with a view to their suitability for the intended processes and purposes. Should you require an advice or instructions concerning our products or services, please contact us directly. Users of this website declare that they agree to access the website and its content at their own risk. Neither BAYER nor third parties involved in the writing, production or transmission of this website can be held liable for damage or injury resulting from access or the impossibility of access or from the use or impossibility of use of this website or from the fact that you have relied on information given on this website.
Websites of third-party vendors/links

This website contains links/references to third-party websites. By providing such links, BAYER does not give its approval to their contents. Neither does BAYER accept any responsibility for the availability or the contents of such websites or any liability for damage or injury resulting from the use of such contents, of whatever form. Links to other websites are provided to website users merely for the sake of convenience. Users access such websites at their own risk.
Details supplied by yourself

The user of this website is fully responsible for the content and correctness of details he or she sends to BAYER as well as for the non-violation of any third-party rights that may be involved in such details. The user gives his or her consent for BAYER to store such details and to use the same for the purpose of statistical analysis or for any other specified business purpose, unless the information involves personal details, going beyond master data or usage data. In particular, Bayer is entitled to use the contents of such messages, including ideas, inventions, blueprints, techniques and expertise contained therein, for any purpose, such as the development, production and/or marketing of products or services and to reproduce such information and make it available to third parties without any limitations.
International users

This website is checked, operated and updated by BAYER at Research Triangle Park, North Carolina. It is exclusively intended for use in the United States of America. BAYER gives no guarantee that the details presented on this website are also correct in places outside the United States of America, and, in particular, that products and services will be available with the same appearance, in the same sizes or on the same conditions. Should you call up this website from a place outside the United States of America or download contents from such a place, please note that it is your own responsibility to ensure that you act in compliance with local legislation applicable in that place.
Products mentioned on this website may come in different packaging, in different package sizes, or with different lettering or markings, depending on the country.
In the USA the business of the Bayer Group is conducted by Bayer Corporation and/or Bayer CropScience. Customers in the USA are requested to address to one of these entities.
Sale of BAYER Products
Our products are sold in accordance with the current version of our General Conditions of Sale and Delivery

New CEO of Bayer CropScience

new-ceo-of-bayer-cropscience

New CEO of Bayer CropScience

In-house R&D and innovation has marked the rise of Gharda Chemicals Ltd. (GCL) from a small unit in 1964 to one of the most successful and reputed companies in the field of Agro-chemicals worldwide. A strong and vibrant R&D program and expertise in Process Development coupled with a team of outstanding scientists headed by Dr.K.H.Gharda, has enabled the company to capitalise on superior technology generated in-house. This has led to the production of vital import substitute products and cost-effective Agro-chemicals on a large scale now affordable to even marginal farmers at the national level and a strong competitive international presence, saving foreign-exchange outgo, on one hand and earning significant foreign exchange.

Welcome to the Bayer CropScience home page! Here, you can get all the information you need to help you grow your crops. You can learn about the effectiveness of Bayer CropScience products. Access newsletters and useful online sites. Or communicate with our Customer Interaction Center for crop and product questions or comments. You can do it all at BayerCropScienceUS.com!

Bayer BioScience
IGNITE Herbicide Now Available for LibertyLink Cotton
Cotton growers now have a new alternative in weed control. IGNITE herbicide has received federal registration for use on cotton. This non-selective, contact herbicide that controls more than 100 weeds is now available for use on LibertyLink cotton varieties.

Leverkusen – Professor Dr. Friedrich Berschauer (53), currently a member of the Board of Management of Bayer HealthCare AG and Head of its Animal Health Division, has been named Chairman of the Board of Management of Bayer CropScience AG effective April 1, 2004. He succeeds Dr. Jochen Wulff (64), who will retire after 35 years’ valuable service to Bayer. The new Head of Animal Health will be Dr. Gunnar Riemann (45), presently in charge of the Biological Products Division. Riemann will also join the Board of Management of Bayer HealthCare AG.
Friedrich Berschauer was born in Boms, near Ravensburg in southern Germany, on June 29, 1950. He studied agricultural science at Stuttgart-Hohenheim University, subsequently working as a scientific assistant at the university’s Institute for Animal Nutrition. After obtaining his doctorate in agricultural science in 1977, he joined Bayer AG in 1980 as head of the animal nutrition department at the Pharmaceuticals Research Center in Wuppertal. He held various other positions with Bayer before becoming head of development in the company’s Crop Protection Business Group in 1993.

In 1998 he transferred to the United States, serving as President of the Animal Health Division of Bayer Corporation. In July 2000 he was appointed General Manager of the Animal Health Business Group at Bayer AG. After the reorganization, Berschauer initially was appointed a member of the Bayer HealthCare Executive Committee with responsibility for the Animal Health Division and the Asia-Pacific region. Effective October 1, 2003 he became a member of the Board of Management of Bayer HealthCare AG and the company’s labor director.

Since 1987 Berschauer has been working as an adjunct professor at the University of Stuttgart-Hohenheim. He is married with three children.

….
. Dr. Gunnar Riemann
Gunnar Riemann was born in Hamelin, Germany, on October 26, 1958. He majored in pharmacy and obtained his doctorate at the Technical University of Brunswick, Germany, starting his career with Bayer in 1986 at the Institute for Pharmaceutical Technology in Leverkusen. In 1987 he was appointed manager of a pharmaceuticals production facility. In 1991 Riemann transferred to the United States to work for the Bayer subsidiary then known as Miles Inc. in Elkhart, Indiana, as head of product development for OTC products.

Riemann returned to Leverkusen in 1994 to head up the Household Products Business Unit in the Consumer Care Business Group. In 1996 he was appointed this business group’s regional manager for Asia and South America, and from 1999 until September 2001 he was responsible for Consumer Care’s Europe region. He was then placed in charge of Bayer’s Biological Products Business Group, headquartered in the United States. Riemann also served as an Executive Vice President and Member of the Executive Committee of Bayer Corporation, and on July 1, 2002 joined the Executive Committee of Bayer HealthCare.

Dr. Riemann is married with three children.

….
. Dr. Jochen C. Wulff
Dr. Jochen C. Wulff has been Chairman of the Board of Management of Bayer CropScience since July 1, 2002. After studying and obtaining a doctorate in organic chemistry, he joined the research department of what was then Bayer’s U.S. subsidiary Mobay Corporation in 1968. After holding various positions in the Polyurethanes Business Group, both at Mobay and at Bayer’s headquarters in Leverkusen, he was appointed manager of a dyestuffs production unit in Leverkusen in 1984. He returned to Mobay in 1986 as Executive Vice President Production and Technology, becoming Mobay’s President and Chief Executive Officer in 1990. Dr. Wulff left the United States following the reorganization of Bayer’s U.S. operations. In April 1993 he was appointed General Manager of Bayer AG’s Crop Protection Business Group, which was later successfully realigned and combined with the acquired company Aventis CropScience to form today’s Bayer CropScience AG.

This subgroup of Bayer AG has 20,000 employees, annual sales of about EUR 5.7 billion and is represented in 122 countries. One of the world’s leading innovative crop science companies, it is active in the areas of crop protection, non-agricultural pest control, seeds and plant biotechnology.

Bayer HealthCare AG, also a subgroup of Bayer AG, had sales of some EUR 9.4 billion in 2002. It is among the world’s leading innovative companies in the health care and medical products industry, with a global workforce of more than 34,000. Bayer HealthCare combines the global activities of the Animal Health, Biological Products, Consumer Care, Diagnostics and Pharmaceuticals divisions.

Forward-looking statements
This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in our public reports filed with the Frankfurt Stock Exchange and with the U.S. Securities and Exchange Commission (including our Form 20-F). The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.